Llwytho...
Glutamate modulators in the treatment of obsessive-compulsive disorder
Established treatments for obsessive-compulsive disorder (OCD) are of benefit in approximately 3 of every 4 patients, but refractory disease remains distressingly common, and many treatment responders continue to experience considerable morbidity. This motivates a search for new insights into pathop...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Psychiatr Ann |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517847/ https://ncbi.nlm.nih.gov/pubmed/26236057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3928/00485713-20150602-06 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|